Trichomonas vaginalis

From WikiProjectMed
Jump to navigation Jump to search

Trichomonas vaginalis
Trichomonas vaginalis observed by scanning electron microscopy
Trichomonas vaginalis observed by scanning electron microscopy showing the axostyle (ax), the anterior flagella (af) and the undulating membrane (rf).[1]
Scientific classification edit
Domain: Eukaryota
Phylum: Metamonada
Order: Trichomonadida
Family: Trichomonadidae
Genus: Trichomonas
T. vaginalis
Binomial name
Trichomonas vaginalis
(Donné 1836)

Trichomonas vaginalis is an anaerobic, flagellated protozoan parasite and the causative agent of a sexually transmitted disease called trichomoniasis. It is the most common pathogenic protozoan that infects humans in industrialized countries.[2] Infection rates in men and women are similar but women are usually symptomatic, while infections in men are usually asymptomatic. Transmission usually occurs via direct, skin-to-skin contact with an infected individual, most often through vaginal intercourse. The WHO has estimated that 160 million cases of infection are acquired annually worldwide.[3] The estimates for North America alone are between 5 and 8 million new infections each year, with an estimated rate of asymptomatic cases as high as 50%.[4] Usually treatment consists of metronidazole and tinidazole.[5]


Unlike other parasitic protozoa (Giardia lamblia, Entamoeba histolytica, etc.), Trichomonas vaginalis exists in only one morphological stage, a trophozoite, and cannot encyst. The T. vaginalis trophozoite is oval as well as flagellated, or "pear" shaped as seen on a wet-mount. It is slightly larger than a white blood cell, measuring 9 × 7 μm. Five flagella arise near the cytostome; four of these immediately extend outside the cell together, while the fifth flagellum wraps backwards along the surface of the organism.[6] The functionality of the fifth flagellum is not known. In addition, a conspicuous barb-like axostyle projects opposite the four-flagella bundle. The axostyle may be used for attachment to surfaces and may also cause the tissue damage seen in trichomoniasis infections.[7] The nucleus is usually elongated, and the cytoplasm contains many hydrogenosomes.[6]

While T. vaginalis does not have a cyst form, organisms can survive for up to 24 hours in urine, semen, or even water samples. A nonmotile, round, pseudocystic form with internalized flagella has been observed under unfavorable conditions.[8] This form is generally regarded as a degenerate stage as opposed to a resistant form,[8] although viability of pseudocystic cells has been occasionally reported.[9] The ability to revert to trophozoite form, to reproduce and sustain infection has been described,[10] along with a microscopic cell staining technique to visually discern this elusive form.[11]

Protein function

T. vaginalis lacks mitochondria and therefore necessary enzymes and cytochromes to conduct oxidative phosphorylation. It obtains nutrients by transport through the cell membrane and by phagocytosis. The organism is able to maintain energy requirements by the use of a small amount of enzymes to provide energy via glycolysis of glucose to glycerol and succinate in the cytoplasm, followed by further conversion of pyruvate and malate to hydrogen and acetate in an organelle called the hydrogenosome.[12]

Virulence factors

One of the hallmark features of T. vaginalis is the adherence factors that allow cervicovaginal epithelium colonization in women. The adherence that this organism illustrates is specific to vaginal epithelial cells (VECs) being pH, time and temperature dependent. A variety of virulence factors mediate this process some of which are the microtubules, microfilaments, bacterial adhesins (4), and cysteine proteinases. The adhesins are four trichomonad enzymes called AP65, AP51, AP33, and AP23 that mediate the interaction of the parasite to the receptor molecules on VECs.[13] Cysteine proteinases may be another virulence factor because not only do these 30 kDa proteins bind to host cell surfaces but also may degrade extracellular matrix proteins like hemoglobin, fibronectin or collagen IV.[14]

Genome sequencing and statistics

The T. vaginalis genome is approximately 160 megabases in size[15] – ten times larger than predicted from earlier gel-based chromosome sizing.[16] (The human genome is ~3.5 gigabases by comparison.[17]) As much as two-thirds of the T. vaginalis sequence consists of repetitive and transposable elements, reflecting a massive, evolutionarily recent expansion of the genome. The total number of predicted protein-coding genes is ~98,000, which includes ~38,000 'repeat' genes (virus-like, transposon-like, retrotransposon-like, and unclassified repeats, all with high copy number and low polymorphism). Approximately 26,000 of the protein-coding genes have been classed as 'evidence-supported' (similar either to known proteins, or to ESTs), while the remainder have no known function. These extraordinary genome statistics are likely to change downward as the genome sequence, currently very fragmented due to the difficulty of ordering repetitive DNA, is assembled into chromosomes, and as more transcription data (ESTs, microarrays) accumulate. But it appears that the gene number of the single-celled parasite T. vaginalis is, at minimum, on par with that of its host H. sapiens.[citation needed]

In late 2007 Archived 2019-09-19 at the Wayback Machine was launched as a free, public genomic data repository and retrieval service devoted to genome-scale trichomonad data. The site currently contains all of the T. vaginalis sequence project data, several EST libraries, and tools for data mining and display. TrichDB is part of the NIH/NIAID-funded EupathDB Archived 2019-09-19 at the Wayback Machine functional genomics database project.[18]

Genetic diversity

Recent studies into the genetic diversity of T. vaginalis has shown that there are two distinct lineages of the parasite found worldwide; both lineages are represented evenly in field isolates. The two lineages differ in whether or not T. vaginalis virus (TVV) infection is present. TVV infection in T. vaginalis is clinically relevant in that, when present, TVV has an effect on parasite resistance to metronidazole, a first line drug treatment for human trichomoniasis.[19]


Symptoms and signs

Trichomoniasis, a sexually transmitted infection of the urogenital tract, is a common cause of vaginitis in women, while men with this infection can display symptoms of urethritis as well as symptoms of prostate infection.[6] 'Frothy', greenish vaginal discharge with a 'musty' malodorous smell is characteristic.[20]

Only 2% of women with the infection will have a "strawberry" cervix (colpitis macularis, an erythematous cervix with pinpoint areas of exudation) or vagina on examination.[21][8][22] This is due to capillary hemorrhage.[23]


Some of the complications of T. vaginalis in women include: preterm delivery, low birth weight, and increased mortality as well as predisposing to HIV infection, AIDS, and cervical cancer.[24] T. vaginalis has also been reported in the urinary tract, fallopian tubes, and pelvis and can cause pneumonia, bronchitis, and oral lesions. Condoms are effective at reducing, but not wholly preventing, transmission.[25]

Trichomonas vaginalis infection in males has been found to cause asymptomatic urethritis and prostatitis.[26] It has been proposed that it may increase the risk of prostate cancer; however, evidence is insufficient to support this association as of 2014.[26]

Increased susceptibility to HIV

The damage caused by T. vaginalis to the vaginal epithelium increases a woman's susceptibility to an HIV infection. In addition to inflammation, the parasite also causes lysis of epithelial cells and RBCs in the area leading to more inflammation and disruption of the protective barrier usually provided by the epithelium. Having T. vaginalis also may increase the chances of the infected woman transmitting HIV to her sexual partner(s).[27][28]

Mechanism of infection

Trichomonas vaginalis, a parasitic protozoan, is the etiologic agent of trichomoniasis, and is a sexually transmitted infection.[3][29] More than 160 million people worldwide are annually infected by this protozoan.[3]


Classically, with a cervical smear, infected women may have a transparent "halo" around their superficial cell nucleus but more typically the organism itself is seen with a slight cyanophilic tinge, faint eccentric nuclei, and fine acidophilic granules.[30] It is unreliably detected by studying a genital discharge or with a cervical smear because of their low sensitivity. T. vaginalis is also routinely diagnosed via a wet mount, in which "corkscrew" motility is observed. Currently, the most common method of diagnosis is via overnight culture,[31][32] with a sensitivity range of 75–95%.[33] Newer methods, such as rapid antigen testing and transcription-mediated amplification, have even greater sensitivity, but are not in widespread use.[33] The presence of T. vaginalis can also be diagnosed by PCR, using primers specific for GENBANK/L23861.[34]


Infection is treated and cured with metronidazole[35] or tinidazole. The CDC recommends a one time dose of 2 grams of either metronidazole or tinidazole as the first-line treatment; the alternative treatment recommended is 500 milligrams of metronidazole, twice daily, for seven days if there is failure of the single-dose regimen.[36] Medication should be prescribed to any sexual partner(s) as well because they may be asymptomatic carriers.[20][37]


Alfred Francois Donné (1801–1878) was the first to describe a procedure to diagnose trichomoniasis through "the microscopic observation of motile protozoa in vaginal or cervical secretions" in 1836. He published this in the article entitled, "Animalcules observés dans les matières purulentes et le produit des sécrétions des organes génitaux de l'homme et de la femme" in the journal, Comptes rendus de l'Académie des sciences.[38] With it, he created the binomial name of the parasite as Trichomonas vaginalis.[39]


The biology of T. vaginalis has implications for understanding the origin of sexual reproduction in eukaryotes. T. vaginalis is not known to undergo meiosis, a key stage of the eukaryotic sexual cycle. However, when Malik et al.[40] examined T. vaginalis for the presence of 29 genes known to function in meiosis, they found 27 such genes, including eight of nine genes that are specific to meiosis in model organisms. These findings suggest that the capability for meiosis, and hence sexual reproduction, was present in recent ancestors of T. vaginalis. 21 of the 27 meiosis genes were also found in another parasite Giardia lamblia (also called Giardia intestinalis), indicating that these meiotic genes were present in a common ancestor of T. vaginalis and G. intestinalis. Since these two species are descendants of lineages that are highly divergent among eukaryotes, and the meiotic genes were likely present in a common ancestor of all eukaryotes.[40]

See also


  1. Dias-Lopes G, Saboia-Vahia L, Margotti ET, Fernandes NS, Castro CL, Oliveira FO, Peixoto JF, Britto C, Silva FC, Cuervo P, Jesus JB (October 2017). "Morphologic study of the effect of iron on pseudocyst formation in Trichomonas vaginalis and its interaction with human epithelial cells". Memórias do Instituto Oswaldo Cruz. 112 (10): 664–673. doi:10.1590/0074-02760170032. PMC 5607515. PMID 28953994.
  2. Soper, D (2004). "Trichomoniasis: under control or undercontrolled?". American Journal of Obstetrics and Gynecology. 190 (1): 281–90. doi:10.1016/j.ajog.2003.08.023. PMID 14749674.
  3. 3.0 3.1 3.2 Harp, Djana F.; Chowdhury, Indrajit (2011). "Trichomoniasis: Evaluation to execution". European Journal of Obstetrics & Gynecology and Reproductive Biology. 157 (1): 3–9. doi:10.1016/j.ejogrb.2011.02.024. PMC 4888369. PMID 21440359.
  4. Hook, Edward W. (1999). "Trichomonas vaginalis—No Longer a Minor STD". Sexually Transmitted Diseases. 26 (7): 388–9. doi:10.1097/00007435-199908000-00004. PMID 10458631.
  5. W Evan Secor. "Trichomonas Vaginalis". MedScape. Archived from the original on 2022-10-07. Retrieved 2023-05-26.
  6. 6.0 6.1 6.2 Ash, Lawrence; Orihel, Thomas (2007). Ash & Orihel's Atlas of Human Parasitology (5th ed.). American Society for Clinical Pathology Press. ISBN 9780891891673.
  7. Ryan, Kenneth James; Ray, C. George; Sherris, John C., eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 978-0-8385-8529-0.[page needed]
  8. 8.0 8.1 8.2 Petrin D, Delgaty K, Bhatt R, Garber G (April 1998). "Clinical and microbiological aspects of Trichomonas vaginalis". Clin. Microbiol. Rev. 11 (2): 300–17. doi:10.1128/CMR.11.2.300. PMC 106834. PMID 9564565.
  9. Mielczarek E, Blaszkowska J (November 2015). "Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure". Infection. 44 (4): 447–458. doi:10.1007/s15010-015-0860-0. PMID 26546373. S2CID 33823038.
  10. Hussein EM, Atwa MM (December 2008). "Infectivity of Trichomonas vaginalis pseudocysts inoculated intra-vaginally in mice". Journal of the Egyptian Society of Parasitology. 38 (3): 749–762. PMID 19209760.
  11. Verges J (June 1979). "Les prostatites à trichomonas formes rondes (T.F.R.)" [Prostatitis due to the circular form of trichomonas]. Journal d'Urologie et de Nephrologie (in français). 85 (6): 357–361. ISSN 0021-8200. PMID 490766.
  12. Upcroft, P.; Upcroft, J. A. (2001). "Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa". Clinical Microbiology Reviews. 14 (1): 150–64. doi:10.1128/CMR.14.1.150-164.2001. PMC 88967. PMID 11148007.
  13. Arroyo, R.; Engbring, J.; Alderete, J. F. (1992). "Molecular basis of host epithelial cell recognition by Trichomonas vaginalis". Molecular Microbiology. 6 (7): 853–862. doi:10.1111/j.1365-2958.1992.tb01536.x. PMID 1602965. S2CID 44364966.
  14. Mendoza-Lopez, M. R.; Becerril-Garcia, C.; Fattel-Facenda, L. V.; Avila-Gonzalez, L.; Ruiz-Tachiquin, M. E.; Ortega-Lopez, J.; Arroyo, R. (2000). "CP30, a Cysteine Proteinase Involved in Trichomonas vaginalis Cytoadherence". Infection and Immunity. 68 (9): 4907–12. doi:10.1128/IAI.68.9.4907-4912.2000. PMC 101697. PMID 10948104.
  15. Carlton, J. M.; Hirt, R. P.; Silva, J. C.; Delcher, A. L.; Schatz, M.; Zhao, Q.; Wortman, J. R.; Bidwell, S. L.; et al. (2007). "Draft Genome Sequence of the Sexually Transmitted Pathogen Trichomonas vaginalis". Science. 315 (5809): 207–12. Bibcode:2007Sci...315..207C. doi:10.1126/science.1132894. PMC 2080659. PMID 17218520.
  16. Lehker, M. W.; Alderete, J. F. (1999). "Resolution of Six Chromosomes of Trichomonas vaginalis and Conservation of Size and Number among Isolates". The Journal of Parasitology. 85 (5): 976–9. doi:10.2307/3285842. JSTOR 3285842. PMID 10577741.
  17. Zimmer, C. (2007). "EVOLUTION: Jurassic Genome". Science. 315 (5817): 1358–9. doi:10.1126/science.315.5817.1358. PMID 17347424. S2CID 34154189.
  18. Aurrecoechea, Cristina; Brestelli, John; Brunk, Brian P.; Carlton, Jane M.; Dommer, Jennifer; Fischer, Steve; Gajria, Bindu; Gao, Xin; et al. (2009). "GiardiaDB and TrichDB: integrated genomic resources for the eukaryotic protist pathogens Giardia lamblia and Trichomonas vaginalis". Nucleic Acids Research. 37 (Database issue): D526–30. doi:10.1093/nar/gkn631. PMC 2686445. PMID 18824479.
  19. Conrad, Melissa D.; Gorman, Andrew W.; Schillinger, Julia A.; Fiori, Pier Luigi; Arroyo, Rossana; Malla, Nancy; Dubey, Mohan Lal; Gonzalez, Jorge; Blank, Susan (2012). "Extensive Genetic Diversity, Unique Population Structure and Evidence of Genetic Exchange in the Sexually Transmitted Parasite Trichomonas vaginalis". PLOS Neglected Tropical Diseases. 6 (3): e1573. doi:10.1371/journal.pntd.0001573. PMC 3313929. PMID 22479659.
  20. 20.0 20.1 Nanda, N; Michel, RG; Kurdgelashvili, G; Wendel, KA (2006). "Trichomoniasis and its treatment". Expert Review of Anti-infective Therapy. 4 (1): 125–35. doi:10.1586/14787210.4.1.125. PMID 16441214. S2CID 43515177.
  21. Swygard H, Seña AC, Hobbs MM, Cohen MS (April 2004). "Trichomoniasis: clinical manifestations, diagnosis and management". Sex Transm Infect. 80 (2): 91–5. doi:10.1136/sti.2003.005124. PMC 1744792. PMID 15054166.
  22. Garber GE (January 2005). "The laboratory diagnosis of Trichomonas vaginalis". Can J Infect Dis Med Microbiol. 16 (1): 35–8. doi:10.1155/2005/373920. PMC 2095007. PMID 18159526.
  23. Parija, SubhashChandra; Preethi, V; Mandal, Jharna; Halder, Ajay (2011). "Trichomoniasis: An update". Tropical Parasitology. Medknow. 1 (2): 73–75. doi:10.4103/2229-5070.86934. ISSN 2229-5070. PMC 3593481. PMID 23508486.
  24. Schwebke, J. R.; Burgess, D. (2004). "Trichomoniasis". Clinical Microbiology Reviews. 17 (4): 794–803, table of contents. doi:10.1128/CMR.17.4.794-803.2004. PMC 523559. PMID 15489349.
  25. "Trichomoniasis". CDC Fact Sheet. Centers for Disease Control and Prevention. 2007-12-17. Archived from the original on 2013-02-19. Retrieved 2010-06-11.
  26. 26.0 26.1 Caini, Saverio; Gandini, Sara; Dudas, Maria; Bremer, Viviane; Severi, Ettore; Gherasim, Alin (2014). "Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis". Cancer Epidemiology. 38 (4): 329–338. doi:10.1016/j.canep.2014.06.002. ISSN 1877-7821. PMID 24986642.
  27. Mulla, Summaiyaa; Kosambiya, JK; Desai, Vikask; Shethwala, Nimishad (2009). "Sexually transmitted infections and reproductive tract infections in female sex workers". Indian Journal of Pathology and Microbiology. 52 (2): 198–9. doi:10.4103/0377-4929.48916. PMID 19332911.
  28. Mavedzenge, Sue Napierala; Van der Pol, Barbara; Cheng, Helen; Montgomery, Elizabeth T.; Blanchard, Kelly; de Bruyn, Guy; Ramjee, Gita; Van der Straten, Ariane (2010). "Epidemiological Synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African Women". Sexually Transmitted Diseases. 37 (7): 460–6. doi:10.1097/OLQ.0b013e3181cfcc4b. PMID 20562586. S2CID 19708165.
  29. Johnston VJ, Mabey DC (February 2008). "Global epidemiology and control of Trichomonas vaginalis". Current Opinion in Infectious Diseases. 21 (1): 56–64. doi:10.1097/QCO.0b013e3282f3d999. PMID 18192787. S2CID 39490032.
  30. Powers, Celeste N. (1998). "Diagnosis of Infectious Diseases: a Cytopathologist's Perspective". Clinical Microbiology Reviews. 11 (2): 341–65. doi:10.1128/CMR.11.2.341. PMC 106836. PMID 9564567.
  31. Ohlemeyer, C; Hornberger, L; Lynch, D; Swierkosz, E (March 1998). "Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy". Journal of Adolescent Health. 22 (3): 205–8. doi:10.1016/S1054-139X(97)00214-0. PMID 9502007.
  32. Sood, Seema; Mohanty, Srujana; Kapil, Arti; Tolosa, Jorge; Mittal, Suneeta (2007). "InPouch TV culture for detection of Trichomonas vaginalis" (PDF). The Indian Journal of Medical Research. 125 (4): 567–71. PMID 17598943. Archived from the original (PDF) on 2013-11-04. Retrieved 2023-05-26.
  33. 33.0 33.1 Huppert, Jill S.; Mortensen, Joel E.; Reed, Jennifer L.; Kahn, Jessica A.; Rich, Kimberly D.; Miller, William C.; Hobbs, Marcia M. (2007). "Rapid Antigen Testing Compares Favorably with Transcription-Mediated Amplification Assay for the Detection of Trichomonas vaginalis in Young Women". Clinical Infectious Diseases. 45 (2): 194–8. doi:10.1086/518851. PMID 17578778.
  34. Schirm, Jurjen; Bos, Petra A.J.; Roozeboom-Roelfsema, Irene K.; Luijt, Dirk S.; Möller, Lieke V. (2007). "Trichomonas vaginalis detection using real-time TaqMan PCR". Journal of Microbiological Methods. 68 (2): 243–7. doi:10.1016/j.mimet.2006.08.002. PMID 17005275.
    "Trichomonas vaginalis repeated DNA target for PCR identification". GenBank Nucleotide Database. 2002-04-16. L23861.1. Archived from the original on 2022-05-24. Retrieved 2023-05-26.
    Kengne P, Veas F, Vidal N, Rey JL, Cuny G (September 1994). "Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis". Cell. Mol. Biol. (Noisy-le-grand). 40 (6): 819–31. PMID 7812190.
  35. "Metronidazole". Archived from the original on 30 January 2021. Retrieved 23 February 2018.
  36. Workowski, K.A.; Berman, S.; Centers for Disease Control and Prevention (CDC) (17 December 2010). "Sexually transmitted diseases treatment guidelines, 2010" (PDF). MMWR Recomm Rep. 59 (RR-12): 1–110. PMID 21160459. Archived (PDF) from the original on 12 August 2017. Retrieved 26 May 2023. Erratum in: MMWR Recomm Rep. 2011 Jan 14;60(1):18.
  37. Cudmore, S. L.; Delgaty, K. L.; Hayward-Mcclelland, S. F.; Petrin, D. P.; Garber, G. E. (2004). "Treatment of Infections Caused by Metronidazole-Resistant Trichomonas vaginalis". Clinical Microbiology Reviews. 17 (4): 783–93, table of contents. doi:10.1128/CMR.17.4.783-793.2004. PMC 523556. PMID 15489348.
  38. Donné, A. (19 September 1836). "Animalcules observés dans les matières purulentes et le produit des sécrétions des organes génitaux de l'homme et de la femme". Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences (in français). 3: 385–386. Archived from the original on 24 May 2022. Retrieved 26 May 2023.
  39. Diamantis, Aristidis; Magiorkinis, Emmanouil; Androutsos, George (2009). "Alfred Francois Donné (1801-78): a pioneer of microscopy, microbiology and haematology". Journal of Medical Biography. 17 (2): 81–87. doi:10.1258/jmb.2008.008040. ISSN 0967-7720. PMID 19401511. S2CID 9287263. Archived from the original on 2022-10-18. Retrieved 2023-05-26.
  40. 40.0 40.1 Malik SB, Pightling AW, Stefaniak LM, Schurko AM, Logsdon JM (2008). "An expanded inventory of conserved meiotic genes provides evidence for sex in Trichomonas vaginalis". PLOS ONE. 3 (8): e2879. Bibcode:2008PLoSO...3.2879M. doi:10.1371/journal.pone.0002879. PMC 2488364. PMID 18663385.

Further reading

External links